Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 3:25 pm Purchase |
2024-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 2,373,404 11.400% |
167,058 (+7.57%) |
Filing History |
| 2025-02-13 3:10 pm Unchanged |
2024-12-31 | 13G | Tectonic Therapeutic, Inc. TECX |
BML Investment Partners, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-02-13 2:26 pm Purchase |
2024-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
BML Investment Partners, L.P. | 14,250,000 13.300% |
4,854,066 (+51.66%) |
Filing History |
| 2025-02-04 11:11 am Unchanged |
2025-02-03 | 13D | Aadi Bioscience, Inc. AADI |
BML Investment Partners, L.P. | 2,435,000 9.900% |
0 (Unchanged) |
Filing History |
| 2025-01-30 3:32 pm Unchanged |
2025-01-30 | 13D | Aadi Bioscience, Inc. AADI |
BML Investment Partners, L.P. | 2,435,000 9.900% |
0 (Unchanged) |
Filing History |
| 2024-12-31 3:44 pm Purchase |
2024-12-23 | 13G | Ikena Oncology, Inc. IKNA |
BML Investment Partners, L.P. | 3,645,866 7.600% |
3,645,866 (New Position) |
Filing History |
| 2024-12-31 11:13 am Purchase |
2024-12-31 | 13D | Aadi Bioscience, Inc. AADI |
BML Investment Partners, L.P. | 2,435,000 9.900% |
1,051,183 (+75.96%) |
Filing History |
| 2024-12-16 09:50 am Purchase |
2024-12-13 | 13D | Atea Pharmaceuticals, Inc. AVIR |
BML Investment Partners, L.P. | 7,216,312 8.500% |
1,614,233 (+28.81%) |
Filing History |
| 2024-12-12 12:29 pm Purchase |
2024-12-06 | 13G | PMV Pharmaceuticals, Inc. PMVP |
BML Investment Partners, L.P. | 3,269,907 6.300% |
3,269,907 (New Position) |
Filing History |
| 2024-11-07 1:15 pm Purchase |
2024-11-01 | 13G | Athira Pharma, Inc. ATHA |
BML Investment Partners, L.P. | 2,484,445 6.500% |
2,484,445 (New Position) |
Filing History |
| 2024-11-07 12:50 pm Purchase |
2024-11-01 | 13G | ESSA Pharma Inc. EPIX |
BML Investment Partners, L.P. | 4,183,223 9.400% |
4,183,223 (New Position) |
Filing History |
| 2024-10-09 11:40 am Purchase |
2024-10-09 | 13G | OnKure Therapeutics, Inc. OKUR |
BML Investment Partners, L.P. | 447,815 3.500% |
447,815 (New Position) |
Filing History |
| 2024-09-25 7:14 pm Purchase |
2024-09-19 | 13G | Achilles Therapeutics plc ACHL |
BML Investment Partners, L.P. | 4,100,002 9.970% |
4,100,002 (New Position) |
Filing History |
| 2024-09-16 4:42 pm Purchase |
2024-09-10 | 13G | Oramed Pharmaceuticals Inc. ORMP |
BML Investment Partners, L.P. | 2,048,634 5.000% |
2,048,634 (New Position) |
Filing History |
| 2024-08-28 4:42 pm Purchase |
2024-08-28 | 13G | Aadi Bioscience, Inc. AADI |
BML Investment Partners, L.P. | 1,383,817 5.600% |
1,383,817 (New Position) |
Filing History |
| 2024-08-14 9:23 pm Purchase |
2024-08-14 | 13G | Talis Biomedical Corporation TLIS |
BML Investment Partners, L.P. | 203,569 11.200% |
69,484 (+51.82%) |
Filing History |
| 2024-08-14 9:00 pm Purchase |
2024-08-14 | 13G | AN2 Therapeutics, Inc. ANTX |
BML Investment Partners, L.P. | 5,749,432 19.300% |
1,500,000 (+35.30%) |
Filing History |
| 2024-08-14 8:44 pm Purchase |
2024-08-07 | 13G | Talis Biomedical Corporation TLIS |
BML Investment Partners, L.P. | 134,085 7.400% |
134,085 (New Position) |
Filing History |
| 2024-08-12 4:48 pm Purchase |
2024-08-09 | 13G | AN2 Therapeutics, Inc. ANTX |
BML Investment Partners, L.P. | 4,249,432 14.200% |
4,249,432 (New Position) |
Filing History |
| 2024-07-22 4:24 pm Purchase |
2024-07-17 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 2,206,346 10.600% |
1,065,346 (+93.37%) |
Filing History |